Mark R Somerfield

27PUBLICATIONS
131CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Liquid biopsiesCancer geneticsCancer diagnosisPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Aug 26, 2026
Medical Therapy for Hormone Receptor-Positive, HER2-Negative Stage I-III Breast Cancer: ASCO Living Guideline, Version 2026.1.0.

|Jul 16, 2026
Breast Cancer Follow-Up and Surveillance After Primary Treatment: ASCO Guideline Update.

|Apr 10, 2025
Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Update.

Ko Un Park, Mark R Somerfield, Nirupama Anne

|May 20, 2024
Optimal Adjuvant Chemotherapy and Targeted Therapy for Early Breast Cancer-Cyclin-Dependent Kinase 4 and 6 Inhibitors: ASCO Guideline Rapid Recommendation Update.

Rachel A Freedman, Jennifer L Caswell-Jin, Michael Hassett

|Mar 13, 2024
Endocrine and Targeted Therapy for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer-Capivasertib-Fulvestrant: ASCO Rapid Recommendation Update.

Harold J Burstein, Angela DeMichele, Lesley Fallowfield

|Jan 04, 2024
Germline Testing in Patients With Breast Cancer: ASCO-Society of Surgical Oncology Guideline.

Isabelle Bedrosian, Mark R Somerfield, Maria Isabel Achatz

Pageof 5

Frequent Collaborators

5 joint publications

N Lynn Henry

5 joint publications

Rachel A Freedman

5 joint publications

Angela DeMichele

5 joint publications

Sharon H Giordano